Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001072613-15-000433
Filing Date
2015-10-14
Accepted
2015-10-14 09:02:10
Documents
1
Group Members
ANTHONY A. FLORENCE JR.DAVID M. MOTTFOREST BASKETTHARRY R. WELLERKRISHNA S. KOLLURIM. JAMES BARRETTNEA 14 GP LTDNEA PARTNERS 14 L.P.PATRICK J. KERINSPETER J. BARRISPETER W. SONSINIRAVI VISWANATHANSCOTT D. SANDELL

Document Format Files

Seq Description Document Type Size
1 MIRNA THERAPEUTICS, INC. mirna-sch13d_17861.htm SC 13D 518996
  Complete submission text file 0001072613-15-000433.txt   520928
Mailing Address 2150 WOODWARD ST., SUITE 100 AUSTIN TX 78744
Business Address 2150 WOODWARD ST., SUITE 100 AUSTIN TX 78744 512-681-5252
Mirna Therapeutics, Inc. (Subject) CIK: 0001527599 (see all company filings)

EIN.: 261824804 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-89131 | Film No.: 151157316
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1954 GREENSPRING DRIVE SUITE 600 TIMONIUM MD 21093
Business Address 1954 GREENSPRING DRIVE SUITE 600 TIMONIUM MD 21093 410-842-4000
New Enterprise Associates 14, L.P. (Filed by) CIK: 0001544328 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13D